Author

M. Franzese

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Is EV-miR-126-5p a molecular link between impaired glucose metabolism and coronary atherosclerosis?

Atherosclerosis is still the major cause of cardiovascular morbidity and mortality in Western Countries. Attention on cardiometabolic and vascular risk factors, including prediabetes/diabetes, hypertension, and dyslipidaemia is rising.NoncodingRNAs (ncRNAs) have emerged as key regulators of gene expression. They...

R. Ragusa, M. Nordström, M. Occhipinti et al. · European Heart Journal · 0 citations

Open access Oct 2026

Impact of cardiometabolic risk factors on coronary atherosclerotic disease phenotypes, plaque burden and composition in patients with chronic coronary syndromes

Coronary artery disease (CAD) is still the major cause of cardiovascular mortality and morbidity. Despite progresses in treatment a substantial residual risk (RR) of CAD and associated events persists. The role of cardiometabolic determinants of RR is emerging but the relationship with CAD risk phenotypes in pati...

D. Neglia, M. Occhipinti, K. Pane et al. · European Heart Journal · 0 citations

Open access Oct 2026

Exercise echocardiography of left ventricular diastolic function in patients with different clinical conditions and cardiovascular risk factors: functional significance and prognostic impact

Pulmonary vascular pressures are flow-dependent, with invasively determined upper limits of normal pulmonary artery wedge pressure (PAWP) defined by a PAWP–cardiac output (CO) relationship of approximately 2 mmHg/L/min. Accordingly, flow-corrected indices such as the ratio of mitral Doppler E to tissue Doppler e'...

F. Ferrara, A. Esposito, M. Zanfardino et al. · European Heart Journal · 0 citations